IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2

被引:0
作者
Zhu, XD
Jacobs, B
Boetticher, E
Myou, S
Meliton, A
Sano, H
Lambertino, AT
Muñoz, NM
Leff, AR
机构
[1] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Neurobiol Pharmacol & Physiol Pediat Anesthe, Chicago, IL 60637 USA
[3] Univ Chicago, Comm Clin Pharmacol Cell Physiol & Mol Med, Div Biol Sci, Chicago, IL 60637 USA
[4] Tottori Univ, Dept Internal Med 3, Tottori, Japan
关键词
adhesion molecules; signal transduction; arachidonic acid;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We examined the mechanism by which interleukin (IL)-5 causes beta(2)-integrin adhesion of human eosinophils. IL-5 caused time-dependent activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and p38alpha in eosinophils as detected by their phosphorylation. Preincubation of eosinophils with U0126, a mitogen-activated protein kinase/ERK kinase inhibitor, suppressed IL-5-induced activation of cytosolic phospholipase A(2) (cPLA(2)) and eosinophil adhesion, and p38 inhibition by SB203580 had neither effect. ERK1/2 phosphorylation and eosinophil adhesion were blocked by inhibition of the src-family tyrosine kinase, Janus tyrosine kinase (JAK)2, or phosphoinositide-3 kinase (PI3K). Coimmunoprecipitation assay demonstrated that Lyn, a src-family tyrosine kinase, was constitutively associated with PI3K. Inhibition of src-tyrosine kinase but not JAK2 suppressed PI3K activation. Our data suggest that IL-5 induces beta(2)-integrin adhesion of human eosinophils by regulation of cPLA2 activation caused by ERK1/2 phosphorylation. This phosphorylation results from activation of PI3K and protein tyrosine kinases. We also find that src-family tyrosine kinase, possibly Lyn, is the upstream kinase causing PI3K activation.
引用
收藏
页码:1046 / 1053
页数:8
相关论文
共 50 条
  • [21] 5-HT1B Receptor-Mediated Activation of ERK1/2 Requires Both Gαi/o and β-Arrestin Proteins
    Liu, Yusha
    Gibson, Alec W.
    Levinstein, Marjorie R.
    Lesiak, Atom J.
    Ong, Shao-En
    Neumaier, John F.
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (07): : 3143 - 3153
  • [22] Increased erythropoiesis of β-thalassaemia/Hb E proerythroblasts is mediated by high basal levels of ERK1/2 activation
    Wannatung, Tirawat
    Lithanatudom, Pathrapol
    Leecharoenkiat, Amporn
    Svasti, Saovaros
    Fucharoen, Suthat
    Smith, Duncan R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (05) : 557 - 568
  • [23] Glycine-induced cytoprotection is mediated by ERK1/2 and AKT in renal cells with ATP depletion
    Jiang, Linglin
    Qin, Xia
    Zhong, Xiaozheng
    Liu, Li
    Jiang, Li
    Lu, Yan
    Fan, Leming
    He, Zhigang
    Chen, Qi
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2011, 90 (04) : 333 - 341
  • [24] HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK1/2 activation
    Pu, H
    Tian, J
    Andras, IE
    Hayashi, K
    Flora, G
    Hennig, B
    Toborek, M
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (10) : 1325 - 1335
  • [25] SOCS-1 inhibits TNF-α-induced cardiomyocyte apoptosis via ERK1/2 pathway activation
    Yan, Ling
    Tang, Qizhu
    Shen, Difei
    Peng, Sheng
    Zheng, Qian
    Guo, Haipeng
    Jiang, Ming
    Deng, Wei
    INFLAMMATION, 2008, 31 (03) : 180 - 188
  • [26] SOCS-1 Inhibits TNF-α-Induced Cardiomyocyte Apoptosis via ERK1/2 Pathway Activation
    Ling Yan
    Qizhu Tang
    Difei Shen
    Sheng Peng
    Qian Zheng
    Haipeng Guo
    Ming Jiang
    Wei Deng
    Inflammation, 2008, 31 : 180 - 188
  • [27] Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation
    Chang, Chiung-wen
    Poteet, Ethan
    Schetz, John A.
    Gumus, Zeynep H.
    Weinstein, Harel
    NEUROPHARMACOLOGY, 2009, 56 : 213 - 225
  • [28] Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation
    Luwor, Rodney B.
    Chin, Xiaowen
    McGeachie, Andrew B.
    Robinson, Phillip J.
    Zhu, Hong-Jian
    GROWTH FACTORS, 2012, 30 (04) : 220 - 229
  • [29] Prostaglndin E1 inhibits IL-6-induced MCM expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation
    Sobota, Radoslaw M.
    Mueller, Pia J.
    Heinrich, Peter C.
    Schaper, Fred
    BIOCHEMICAL JOURNAL, 2008, 412 (01) : 65 - 72
  • [30] β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells
    Wang, Zhao
    Li, Zhuoran
    Bal, Guerkan
    Franke, Kristin
    Zuberbier, Torsten
    Babina, Magda
    FRONTIERS IN ALLERGY, 2022, 3